Transcript PowerPoint

Analgesics and hypnotics
(APA Cambridge 20. June 2013
Tom G. Hansen, MD, PhD,
Department of Anaesthesia & Intensive Care
Odense University Hospital
& University of Southern Denmark
DENMARK
Email: [email protected]
Topics covered
• Some news about old drugs
• Something about a new drug
• Focus: neonates and infants
• Focus: outcome, safety and
toxicity
Propofol, neonates and
haemodynamics
Demographics
Haemodynamics
NIRS
Authors’ conclusions
Endpoints?
• Biomarkers for CNS injury (Neuron-specific enolase
(NSE) and s-100β protein (t=0 h, after CPB, 6 h, 24 h,
48 h)
• Inflammatory mediators
• Bayley Scales of Infant Development, 2nd Ed (BSIDII) before and 2-3 w after surgery
• MRI with spectroscopy (MRS) just before surgery
and just before hospital discharge (n=5): N-acetyl
aspartate (NAA), creatine (Cr) and
glutamate/glutamine sum
• NIRS < 24 h
NSE and CRP
Conclusions
Dexmedetomidine
(2 adrenergic agonist)
Dexmedetomedine
(Mason & Lerman Anesth Analg 2011)
Licenced for PICU  OR+sedation (resp)
Problems: PK/PD
Infants & neonates?
slow onset/prolonged duration
indication?
haemodynamics (BP↓↑,HR↓)
premedication?
drug synergism?
Dexmedetomidine attenuates isofluraneinduced neuroapoptosis
Sanders et al. Acta Anaesthesiol Scand
2010
Sanders et al. Anesthesiology 2009
(Caspase 3-activation↓)
Context sensitive half times of opioids
Ideal opioid for neonates and infants?
Tolerance and hyperalgesia?
NICU/PICU?
MAC↓  Neurotoxcicity?
NEOPAIN (Anand et al Lancet 2004; 363: 1673-82)
RCT, 16 centers: IPPV treated preterm infants, Morphine group
(MG; n=449) and placebo group (PG; n=449)
Intervention: preemptive morphine in IPPV
LD 0.1 mg/kg, followed by CI 10 g/kg/h (GA 23-26)
20 g/kg/h (GA 27-29)
30 g/kg/h (GA 30-32)
+ open label morphine (OLM) for both groups
Composite primary outcome: Death, IVH and PVL
Results: Analgesia  but similar rates of deaths, IVH and PVL
- OLM  ↑CO and ↑severe IVH in MG vs. PG
+ OLM  ↑CO in PG
+OLM  IVH in MG
Long term outcome
Long term outcome
The original Dutch studies (2000-2002)
Simons et al. JAMA 2003; 290: 2419-27
Simons et al. Arch Dis Child Fetal Neonatal Ed
2005; 90: F36-40
Simons et al. Arch Dis Child Fetal Neonatal Ed
2006; 91: F46-51
Placebo-controlled RCT (n=150) in preterms on
IPPV receiving morphine: LD 0.1 mg/kg CI 10 g/kg/h
+open label morphine: LD 0.05 mg/kg, CI 5-10 g/kg/h
IVH  in morphine group, but similar analgesia and
neurological outcome
Conclusions
• Carefull dosing of anaesthetics and analgesics
in very premature infants
• Impact of haemodynamics on anaesthesiainduced neurotoxicity?
• Normal blood pressure?
• How do we treat hypotension?